Rocket Pharmaceuticals Announces Positive Clinical Data From RP-L201 Trial For The Treatment Of LAD-I At The 28th Annual Congress Of The European Society Of Gene & Cell Therapy (ESGCT)

Jonathan Schwartz,

Press/Media

Period	20 Oct 2021

Media coverage

24

Media coverage

Title	Rocket Pharmaceuticals Announces Positive Clinical Data From RP-L201 Trial For The Treatment Of LAD-I At The 28th Annual Congress Of The European Society Of Gene & Cell Therapy (ESGCT)
Media name/outlet	TheStreet.com
Country/Territory	United States
Date	20/10/21
URL	https://www.thestreet.com/press-releases/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad-i-at-the-28th-annual-congress-of-the-european-society-of-gene-amp-cell-therapy-esgct-15804902
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals : Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	MarketScreener.com
Country/Territory	United States
Date	20/10/21
URL	https://www.marketscreener.com/quote/stock/ROCKET-PHARMACEUTICALS-I-40561561/news/Rocket-Pharmaceuticals-Announces-Positive-Clinical-Data-from-RP-L201-Trial-for-the-Treatment-of-LA-36725089/
Persons	Jonathan Schwartz,

Title	$RCKT Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	OTC Dynamics
Country/Territory	Canada
Date	20/10/21
URL	https://www.otcdynamics.com/rckt-rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad-i-at-the-28th-annual-congress-of-the-european-society-of-gene-cell-therapy-esgct/
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT); -RP-L201 is well tolerated and leads to durable CD18 expression and c
Media name/outlet	Business Wire
Country/Territory	United States
Date	20/10/21
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Business Wire
Country/Territory	United States
Date	20/10/21
URL	www.businesswire.com/news/home/20211020005316/en
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Morningstar.com
Country/Territory	United States
Date	20/10/21
URL	https://www.morningstar.com/news/business-wire/20211020005316/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad-i-at-the-28th-annual-congress-of-the-european-society-of-gene-cell-therapy-esgct
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	BioSpace
Country/Territory	United States
Date	20/10/21
URL	https://www.biospace.com/article/releases/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad-i-at-the-28th-annual-congress-of-the-european-society-of-gene-and-cell-therapy-esgct-/
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	ADVFN UK
Country/Territory	United Kingdom
Date	20/10/21
URL	https://uk.advfn.com/stock-market/NASDAQ/RCKT/share-news/Rocket-Pharmaceuticals-Announces-Positive-Clinical/86324449
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Yahoo! News
Country/Territory	United States
Date	20/10/21
URL	https://www.yahoo.com/now/rocket-pharmaceuticals-announces-positive-clinical-070000096.html
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Yahoo! Finance
Country/Territory	United States
Date	20/10/21
URL	https://finance.yahoo.com/news/rocket-pharmaceuticals-announces-positive-clinical-070000096.html
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Stockwatch
Country/Territory	Canada
Date	20/10/21
URL	www.stockwatch.com/News/Item/U-b20211020005316-U!RCKT-20211020/U/RCKT
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Maryville Daily Times
Country/Territory	United States
Date	20/10/21
URL	https://www.thedailytimes.com/business/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad/article_541f1c84-b956-5dec-abbf-5f8444f81261.html
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Crwe World
Country/Territory	United States
Date	20/10/21
URL	crweworld.com/article/news-provided-by-business-wire/2167346/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad-i-at-the-28th-annual-congress-of-the-european-society-of-gene-amp-cell-therapy-esgct
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	TD Ameritrade
Country/Territory	United States
Date	20/10/21
URL	https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-293b4793
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Market Newsdesk
Country/Territory	United States
Date	20/10/21
URL	https://www.marketnewsdesk.com/index.php/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad-i-at-the-28th-annual-congress-of-the-european-society-of-gene-cell-therapy-esgct/
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	ADVFN US
Country/Territory	United States
Date	20/10/21
URL	https://www.advfn.com/p.php?pid=nmona&article=86324449
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	PipelineReview
Country/Territory	Spain
Date	20/10/21
URL	https://pipelinereview.com/index.php/2021102079454/DNA-RNA-and-Cells/Rocket-Pharmaceuticals-Announces-Positive-Clinical-Data-from-RP-L201-Trial-for-the-Treatment-of-LAD-I-at-the-28th-Annual-Congress-of-the-European-Society-of-Gene-Cell-T.html
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Jotup
Country/Territory	United States
Date	20/10/21
URL	https://jotup.co/node/1570020
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Spoke.com
Country/Territory	United States
Date	20/10/21
URL	https://www.spoke.com/press_releases/616fd4e238b31461e200aeee
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Bakersfield.com
Country/Territory	United States
Date	20/10/21
URL	https://www.bakersfield.com/ap/news/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad/article_e5fdc5ac-1fe4-5885-a3ab-72091d4f7059.html
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Elk Valley Times
Country/Territory	United States
Date	20/10/21
URL	https://www.elkvalleytimes.com/news/business/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad/article_b995d9ef-f063-54c5-b0b1-7317b1880130.html
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	The Argus-Press
Country/Territory	United States
Date	20/10/21
URL	https://www.argus-press.com/news/national/article_a54968ba-5739-52a8-a783-5760bb1c5ee5.html
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Ludington Daily News
Country/Territory	United States
Date	20/10/21
URL	https://www.shorelinemedia.net/ludington_daily_news/business/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad/article_86021bf4-d49d-56fc-8327-647868425518.html
Persons	Jonathan Schwartz,

Title	Rocket Pharmaceuticals Announces Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Media name/outlet	Digital Media Net
Country/Territory	United States
Date	20/10/21
URL	dmnnewswire.digitalmedianet.com/2021/10/20/rocket-pharmaceuticals-announces-positive-clinical-data-from-rp-l201-trial-for-the-treatment-of-lad-i-at-the-28th-annual-congress-of-the-european-society-of-gene-cell-therapy-esgct/
Persons	Jonathan Schwartz,